[an error occurred while processing this directive]
|
|||||||||
CHM3931Medicinal Chemistry (6 points)(SCI) Leader: Dr Peter Junk
Offered: Synopsis: This subject focuses on several major classes of biologically and clinically important therapeutic agents. Students will study the traditional use, isolation, structural characterisation, sythesis and clinical evaluation of drugs and also be exposed to newer crystallographic, computational, combinatorial and screening methodology used in drug design and development. The subject will consist of three inter-related sections: a) drug discovery and development, b) molecular recognition and c) combinatorial chemistry and the synthesis of biological polymers. Where appropriate, guest speakers from industry and government agencies will contribute to the subject. Assessment: One 2.5 hour examination: 60% + Seminar/ Asssignments: 10% + Laboratory work and short laboratory reports: 30% Contact Hours: Two 1-hour lectures, one 1-hour tutorial and the equivalent of 3 hours of laboratory activity per week Prerequisites: 12 points of level-one chemistry and normally CHM2911 or CHM2912 or CHM2942 and 6 other points of level-two chemistry, students without these should consult the coordinator |
Australian Government Requirements for International Students - CRICOS Provider Number: 00008C
Copyright © 1994-2001 Monash University - Last Date Modified: 13 October 2003 - Caution - Privacy Monash University ABN 12 377 614 012 |